Economics of the medical industry
The economics of the medical industry describes the financial structures of healthcare — including the fee-for-service model, pharmaceutical industry profit incentives, insurance systems, and the legacy of the Flexner Report — that critics argue systematically prioritize profitable treatments over cures, incentivize chronic disease management over prevention, and suppress alternative modalities that cannot be patented.
Rockefeller origins
Jesse Michels traced the modern medical industry's economic structure to John D. Rockefeller's early 20th century project to "monopolize medicine in the same way that he had oil." Rockefeller's investment in Johns Hopkins University and other medical schools, combined with the Flexner Report's elimination of schools teaching holistic medicine, osteopathy, and other non-pharmaceutical approaches, created a system in which "only one kind of treatment was allowed to exist" — a system designed around the patentability and profitability of petroleum-derived synthetic pharmaceuticals.
Michels further noted that the Rockefeller Foundation's president, Detlev Bronk, was allegedly a member of the Majestic 12 committee while simultaneously serving as president of Johns Hopkins, which "clears, I think, like $8 billion a year for medical research" — suggesting an overlap between UFO secrecy governance and medical research funding.
Shift from acute to chronic care
Calley Means described a deliberate transition in the mid-20th century from a medical system focused on acute care — "emergency surgical procedures, sanitation procedures, antibiotics" — to one centered on managing chronic conditions that require lifelong pharmaceutical dependence. The birth control pill, introduced in the late 1950s, was "the 1st pill in world history that people took for longer than a couple of weeks" — establishing the pharmaceutical model of long-term medication as a revenue stream. By the 2020s, 90 to 95 percent of healthcare spending was devoted to chronic condition management. This advertising revenue creates a conflict of interest in which news organizations are financially disincentivized from reporting critically on pharmaceutical products or the broader medical industry.[citation needed]
The Sackler model
Means traced the modern pharmaceutical profit model to the Sackler family, whose earlier generation created Valium — at one point prescribed to 30 percent of American women — before their descendants developed the OxyContin opioid franchise, demonstrating the multigenerational business model of creating pharmaceutical dependence for chronic or behavioral conditions.
Suppressed medical technologies
Main article:
Technology suppression
Michels described a parallel between UFO secrecy and medical secrecy, arguing that "just like in UFO world, where you have obvious fake footage, you have institutionalized official narratives... in the health world, there's snake oil, but there's also very likely a group of suppressed real breakthroughs." He cited the case of Royal Raymond Rife, whose 1930s electromagnetic frequency device was reportedly used to treat cancer patients in a California clinic before being suppressed.
The Joe Rogan Experience interview with Calley Means and Casey Means covering the economics of the medical industry, the Rockefeller healthcare model, and the Flexner Report's legacy is also available on YouTube.
See also
- Economics of fundamental and applied scientific and biomedical research
- Corruption and conflicts of interest in popular media platforms